297 related articles for article (PubMed ID: 24574341)
1. Targeting miR-21 to treat psoriasis.
Guinea-Viniegra J; Jiménez M; Schonthaler HB; Navarro R; Delgado Y; Concha-Garzón MJ; Tschachler E; Obad S; Daudén E; Wagner EF
Sci Transl Med; 2014 Feb; 6(225):225re1. PubMed ID: 24574341
[TBL] [Abstract][Full Text] [Related]
2. Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in a mouse model.
Sato K; Takaishi M; Tokuoka S; Sano S
PLoS One; 2014; 9(11):e112408. PubMed ID: 25384035
[TBL] [Abstract][Full Text] [Related]
3. Signalling in inflammatory skin disease by AP-1 (Fos/Jun).
Uluçkan Ö; Guinea-Viniegra J; Jimenez M; Wagner EF
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S44-9. PubMed ID: 26458100
[TBL] [Abstract][Full Text] [Related]
4. MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis.
Meisgen F; Xu N; Wei T; Janson PC; Obad S; Broom O; Nagy N; Kauppinen S; Kemény L; Ståhle M; Pivarcsi A; Sonkoly E
Exp Dermatol; 2012 Apr; 21(4):312-4. PubMed ID: 22417311
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and potential target interactions in psoriasis.
Zibert JR; Løvendorf MB; Litman T; Olsen J; Kaczkowski B; Skov L
J Dermatol Sci; 2010 Jun; 58(3):177-85. PubMed ID: 20417062
[TBL] [Abstract][Full Text] [Related]
6. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis.
Schukur L; Geering B; Charpin-El Hamri G; Fussenegger M
Sci Transl Med; 2015 Dec; 7(318):318ra201. PubMed ID: 26676608
[TBL] [Abstract][Full Text] [Related]
7. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation.
Su F; Jin L; Liu W
Dermatology; 2021; 237(4):568-578. PubMed ID: 33735868
[TBL] [Abstract][Full Text] [Related]
9. Downregulated miR-187 contributes to the keratinocytes hyperproliferation in psoriasis.
Tang L; He S; Zhu Y; Feng B; Su Z; Liu B; Xu F; Wang X; Liu H; Li C; Zhao J; Zheng X; Li C; Sun C; Lu C; Zheng G
J Cell Physiol; 2019 Apr; 234(4):3661-3674. PubMed ID: 30607907
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
Yan JJ; Qiao M; Li RH; Zhao XT; Wang XY; Sun Q
Br J Dermatol; 2019 Feb; 180(2):365-372. PubMed ID: 30269330
[TBL] [Abstract][Full Text] [Related]
11. hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes.
Chowdhari S; Saini N
J Cell Physiol; 2014 Nov; 229(11):1630-8. PubMed ID: 24610393
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNA-21 and TIMP-3 in paradoxical psoriasiform reactions during treatment with antitumor necrosis factor agents.
Navarro R; Delgado-Jiménez Y; Guinea-Viniegra J; Llamas-Velasco M; Daudén E
J Cutan Pathol; 2022 Feb; 49(2):116-122. PubMed ID: 34322902
[TBL] [Abstract][Full Text] [Related]
14. Targeting inflammation by modulating the Jun/AP-1 pathway.
Schonthaler HB; Guinea-Viniegra J; Wagner EF
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i109-12. PubMed ID: 21339212
[TBL] [Abstract][Full Text] [Related]
15. Role of IL-17A signalling in psoriasis and associated bone loss.
Uluçkan Ö; Wagner EF
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):17-20. PubMed ID: 27586798
[TBL] [Abstract][Full Text] [Related]
16. miR-4516, a microRNA downregulated in psoriasis inhibits keratinocyte motility by targeting fibronectin/integrin α9 signaling.
Chowdhari S; Sardana K; Saini N
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3142-3152. PubMed ID: 28844950
[TBL] [Abstract][Full Text] [Related]
17. Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity.
Guo S; Zhang W; Wei C; Wang L; Zhu G; Shi Q; Li S; Ge R; Li K; Gao L; Gao T; Wang G; Li C
Eur J Dermatol; 2013; 23(5):608-13. PubMed ID: 24135466
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-194 regulates keratinocyte proliferation and differentiation by targeting Grainyhead-like 2 in psoriasis.
Yu X; An J; Hua Y; Li Z; Yan N; Fan W; Su C
Pathol Res Pract; 2017 Feb; 213(2):89-97. PubMed ID: 28040329
[TBL] [Abstract][Full Text] [Related]
20. MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2.
Zhu H; Hou L; Liu J; Li Z
Biochem Biophys Res Commun; 2016 Feb; 471(1):169-76. PubMed ID: 26826389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
